Negative prognostic impact of sarcopenia before and after neoadjuvant chemotherapy for pancreatic cancer
29 Nov 2022, 2 p.m.
Publication date: Available online 28 November 2022Source: PancreatologyAuthor(s): Mitsuhiro Shimura, ...
Pancreatology Journal, latest articles
Acute pancreatitis is characterized by generalized intestinal barrier dysfunction in early stage
29 Nov 2022, 2 p.m.
Publication date: Available online 29 November 2022Source: PancreatologyAuthor(s): Samagra Agarwal, ...
Optimising the measurement of intra-bladder pressure in patients with predicted severe acute pancreatitis
29 Nov 2022, 2 p.m.
Publication date: Available online 29 November 2022Source: PancreatologyAuthor(s): Linqian Li, ...
A randomized controlled pilot trial of etanercept and alpha-1 antitrypsin to improve autologous islet engraftment
24 Nov 2022, 10 a.m.
Publication date: Available online 24 November 2022Source: PancreatologyAuthor(s): Tasneem R. ...
Shear-wave versus strain elastography in endoscopic ultrasound for the diagnosis of chronic pancreatitis
24 Nov 2022, 10 a.m.
Publication date: Available online 24 November 2022Source: PancreatologyAuthor(s): Yasunobu Yamashita, ...
Replication stress identifies novel molecular classification associated with treatment outcomes in pancreatic cancer
21 Nov 2022, 10 a.m.
Publication date: Available online 21 November 2022Source: PancreatologyAuthor(s): Zhijun Zhou, ...
Chronological improvement of pancreatectomy for resectable but advanced pancreatic neuroendocrine neoplasms
14 Nov 2022, 10 a.m.
Publication date: Available online 13 November 2022Source: PancreatologyAuthor(s): Takeshi Takamoto, ...
The efficacy and safety of modified FOLFIRINOX for unresectable advanced pancreatic cancer in elderly versus young patients: A multicenter retrospective cohort study
12 Nov 2022, noon
Publication date: Available online 12 November 2022Source: PancreatologyAuthor(s): Ryuichi Tezuka, ...
News (September 2020)
COVIDSurg-Cancer paper accepted by JCO
14th Sep 2020
We are delighted to announce that COVIDSurg-Cancer paper accepted by JCO (impact factor 33), and would like to thank AUGIS/GBIHPBA for their support of the study. read more..